
130.4K
Downloads
268
Episodes
Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization.
Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist consulting firms. Our host Raman is an entrepreneur, investor, bestselling author, speaker and long time industry insider.
https://moleculetomarketpod.com
Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization.
Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist consulting firms. Our host Raman is an entrepreneur, investor, bestselling author, speaker and long time industry insider.
Episodes

Friday Oct 06, 2023
Designing facilities today for tomorrow’s medicines
Friday Oct 06, 2023
Friday Oct 06, 2023
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gordon Nicholson, Director of the Life Sciences NEA at Exyte.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gordon, covering:
- Transitioning from a regular, technical role into a commercial lead in Asia
- Lessons from sport and going back to basics when breaking down silos at Novo Nordisk Engineering
- Tips for building a presence and doing business in Asia from half a lifetime spent living and working in Thailand, China, and Singapore
- Being at the cutting edge of designing and building modern facilities for biologics, CGTs, and advanced therapies - including the rapid and complex needs of CDMOs
- A glimpse into the future of how CGT products may be made and administered at speed (safely) in the hospital in the next room from the patient
Gordon has more than 30 years of experience in designing and constructing Life Science facilities, from research to commercial production. He has worked on projects in Asia and the US for local and global pharmaceutical and biotechnology customers.
His responsibilities include leading the Life Science Concept Design Team in the Asia Pacific region, supporting clients through Business Development through the Technical review of documents before they are issued to clients.
Please subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital, and content agency helping companies differentiate, get noticed and grow in life sciences.

No comments yet. Be the first to say something!